TrialBritish journal of haematology2011

Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.

Gaetano Corazzelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.